Imeglimin increases glucose‐dependent insulin secretion and improves β‐cell function in patients with type 2 diabetes-Reference-Cited by-同舟云学术

Imeglimin increases glucose‐dependent insulin secretion and improves β‐cell function in patients with type 2 diabetes

Published:2015-03-25 Issue:6 Volume:17 Page:541-545
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Pacini G.¹,Mari A.¹,Fouqueray P.²,Bolze S.²,Roden M.³⁴⁵

Affiliation:

1. Metabolic (Modeling) UnitInstitute of Biomedical Engineering Padova Italy

2. Poxel SA Lyon France

3. Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research Düsseldorf Germany

4. Department of Endocrinology and DiabetologyMedical Faculty, Heinrich‐Heine University Düsseldorf Düsseldorf Germany

5. German Center for Diabetes Research Düsseldorf Germany

Funder

Poxel

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12452

Reference18 articles.

1. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

2. Relationship between lactate dehydrogenase and myeloperoxidase levels in human gingival crevicular fluid and clinical and microbial measurements

3. PubChem Open Chemistry Database.Imeglimin.2008. Available from URL:http://pubchem.ncbi.nlm.nih.gov/compound/24812808#section=Top. Accessed January 2015.

4. Imeglimin Normalizes Glucose Tolerance and Insulin Sensitivity and Improves Mitochondrial Function in Liver of a High-Fat, High-Sucrose Diet Mice Model

5. Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Effect of Imeglimin Add-on Therapy on 24-h Glucose Profile and Glycemic Variability in Patients with Type 2 Diabetes Receiving Metformin;Medical Principles and Practice;2024-08-12

2. Glucokinase activators and imeglimin: new weaponry in the armamentarium against type 2 diabetes;BMJ Open Diabetes Research & Care;2024-08

3. Imeglimin modulates mitochondria biology and facilitates mitokine secretion in 3T3-L1 adipocytes;Life Sciences;2024-07

4. Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high‐fat, high‐sucrose diet‐fed mice;Journal of Diabetes Investigation;2024-06-14

5. Exploring new mechanisms of Imeglimin in diabetes treatment: Amelioration of mitochondrial dysfunction;Biomedicine & Pharmacotherapy;2024-06